Taysha Gene Therapies - 53 Year Dividend History | TSHA
Historical dividend payout and yield for Taysha Gene Therapies (TSHA) since 1971. The current TTM dividend payout for Taysha Gene Therapies (TSHA) as of October 31, 2024 is $0.00. The current dividend yield for Taysha Gene Therapies as of October 31, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.314B |
$0.015B |
|
Taysha Gene Therapies Inc. is a patient-centric gene therapy company. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system. The company's product pipeline includes TSHA-101, TSHA-118, TSHA-102, TSHA-103 and TSHA-104 which are in clinical stage. Taysha Gene Therapies Inc. is based in Dallas, Texas.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
